nitrendipine has been researched along with Insulin Resistance in 6 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Excerpt | Relevance | Reference |
---|---|---|
"Combination therapy of nitrendipine and atenolol may significantly increase BW and fasting BG in overweight or obese patients with hypertension." | 9.14 | Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients. ( Qin, YW; Qiu, JL; Zhang, JL; Zhao, XX; Zheng, X; Zou, DJ, 2009) |
"Combination therapy of nitrendipine and atenolol may significantly increase BW and fasting BG in overweight or obese patients with hypertension." | 5.14 | Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients. ( Qin, YW; Qiu, JL; Zhang, JL; Zhao, XX; Zheng, X; Zou, DJ, 2009) |
"Nitrendipine treatment 1) lowered fasting serum insulin from 265 +/- 24 to 194 +/- 22 pmol/L (P < 0." | 2.67 | Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men. ( Arocha, IR; Beer, NA; Beer, RM; Jakubowicz, DJ; Nestler, JE, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, JL | 1 |
Zheng, X | 1 |
Zou, DJ | 1 |
Qiu, JL | 1 |
Zhao, XX | 1 |
Qin, YW | 1 |
Bursztyn, M | 1 |
Raz, I | 1 |
Mekler, J | 1 |
Ben-Ishay, D | 1 |
Beer, NA | 1 |
Jakubowicz, DJ | 1 |
Beer, RM | 1 |
Arocha, IR | 1 |
Nestler, JE | 1 |
Draznin, B | 2 |
Zhou, YP | 1 |
Cockburn, BN | 1 |
Pugh, W | 1 |
Polonsky, KS | 1 |
Byyny, RL | 1 |
LoVerde, M | 1 |
Lloyd, S | 1 |
Mitchell, W | 1 |
1 review available for nitrendipine and Insulin Resistance
Article | Year |
---|---|
Cytosolic calcium and insulin resistance.
Topics: Animals; Calcium; Humans; Hypertension; Insulin Resistance; Nitrendipine; Obesity | 1993 |
2 trials available for nitrendipine and Insulin Resistance
Article | Year |
---|---|
Effect of metformin on weight gain during antihypertensive treatment with a beta-blocker in Chinese patients.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Body Mass Index | 2009 |
Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.
Topics: Adult; Analysis of Variance; Blood Glucose; Blood Pressure; Dehydroepiandrosterone; Dehydroepiandros | 1993 |
3 other studies available for nitrendipine and Insulin Resistance
Article | Year |
---|---|
Nitrendipine improves glucose tolerance and deoxyglucose uptake in hypertensive rats.
Topics: Animals; Blood Pressure; Deoxyglucose; Glucose; Glucose Tolerance Test; Hypertension; Insulin Resist | 1994 |
Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
Topics: Animals; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus; Diazoxide; Enzyme Inhibitors; G | 1999 |
Cytosolic calcium and insulin resistance in elderly patients with essential hypertension.
Topics: Adipose Tissue; Aged; Aging; Blood Glucose; Calcium; Cytosol; Deoxyglucose; Glucose Tolerance Test; | 1992 |